Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01292655
Title Study to Evaluate the Safety and Tolerability of IV Doses of BMS-906024 in Subjects With Advanced or Metastatic Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

lung non-small cell carcinoma

melanoma

pancreatic cancer

Her2-receptor negative breast cancer

ovarian cancer

Advanced Solid Tumor

Therapies

BMS-906024

Age Groups: adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Anthony El-Khoueiry, Md Los Angeles California 90033 United States Details
Winship Cancer Institute. Atlanta Georgia 30322 United States Details
Wayne State University Detroit Michigan 48201 United States Details
University Of Mississippi Medical Center Jackson Mississippi 39216 United States Details
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232 United States Details
The Methodist Hospital Research Institute Houston Texas 77030 United States Details
Local Institution Parkville Victoria 3050 Australia Details
Local Institution Toronto Ontario M5G 2M9 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field